Effect of irbesartan monotherapy compared with ACE inhibitors and calcium channel blockers on patient compliance in patients with essential hypertension: A multicenter, randomized, open-cohort study

dc.contributor.author	Kabakci, G
dc.contributor.author	Guneri, S
dc.contributor.author	Ilerigelen, B
dc.contributor.author	Onder, R
dc.contributor.author	Sagkan, O
dc.contributor.author	Koylan, N
dc.contributor.author	Acarturk, E
dc.contributor.author	Caglar, N
dc.contributor.author	Caglar, S
dc.contributor.author	Erdine, S
dc.date.accessioned	2021-03-05T13:46:35Z
dc.date.available	2021-03-05T13:46:35Z
dc.identifier.citation	Koylan N., Acarturk E., Caglar N., Caglar S., Erdine S., Guneri S., Ilerigelen B., Kabakci G., Onder R., Sagkan O., "Effect of irbesartan monotherapy compared with ACE inhibitors and calcium channel blockers on patient compliance in patients with essential hypertension: A multicenter, randomized, open-cohort study", 13th European Meeting on Hypertension, Milan, İtalya, 13 - 17 Haziran 2003, cilt.21
dc.identifier.other	vv_1032021
dc.identifier.other	av_b3d26762-7e85-4c31-ada6-357e5cbbd521
dc.identifier.uri	http://hdl.handle.net/20.500.12627/119760
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	PERİFERAL VASKÜLER HASTALIĞI
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.title	Effect of irbesartan monotherapy compared with ACE inhibitors and calcium channel blockers on patient compliance in patients with essential hypertension: A multicenter, randomized, open-cohort study
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	21
dc.contributor.firstauthorID	128615

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.